Retinal Vein Occlusion
📧 Sign up to get email alerts when something new happens for Retinal Vein Occlusion.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2019-08-20Clinical Trial Update: Ranibizumab Treatment for Macular Edema Secondary to Retinal Vein Occlusion [Phase 4]
Phase 4 clinical trial update evaluating ranibizumab for macular edema due to retinal vein occlusion.
-
CLINICAL_TRIALS trial_result · 2019-04-17Clinical Trial Update: Post Intravitreal Injection Topical NSAID vs. Patching [Phase 4]
A Phase 4 trial update comparing post-intravitreal injection topical NSAID versus patching for neovascular age-related macular degeneration …
-
CLINICAL_TRIALS trial_result · 2019-02-20Clinical Trial Update: Efficacy and Safety of Lucentis® (Ranibizumab Intravitreal Injections) in Chilean Patients With Diabetic Macular Edema. [Phase 4]
Phase 4 clinical trial evaluating the efficacy and safety of Lucentis (ranibizumab) in Chilean patients with diabetic macular edema has comp…
-
CLINICAL_TRIALS trial_result · 2018-12-21Clinical Trial Update: To Study the Effectiveness and Safety of Niacin and a Topical Steroid Eye Drop to Treat Retinal Vein Occlusions [Phase 2, Phase 3]
Phase 2 and Phase 3 trial assessing niacin plus a topical steroid eye drop for safety and effectiveness in retinal vein occlusion have compl…
-
CLINICAL_TRIALS trial_result · 2018-08-29Clinical Trial Update: Ziv-aflibercept in Ocular Disease Requiring Anti-VEGF Injection [Phase 2]
Phase 2 trial update for Ziv-aflibercept in ocular diseases requiring anti-VEGF injections.
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2018-06-27Clinical Trial Update: Open Label Study to Assess the Efficacy and Safety of AKB-9778 in Subjects With Macular Edema Due to RVO [Phase 2]
This Phase 2 open-label study assessing AKB-9778 for macular edema due to retinal vein occlusion has completed.
-
CLINICAL_TRIALS research · 2018-06-27Clinical Trial Update: Comfort and Antimicrobial Efficacy of Chlorhexidine vs Betadine for Intravitreal Injections [EARLY_Phase 1]
A Phase 1 trial evaluating chlorhexidine versus povidone-iodine for antimicrobial prophylaxis in intravitreal injections across multiple ret…
-
CLINICAL_TRIALS trial_result · 2018-06-18Clinical Trial Update: Dexamethasone Intravitreal Implant in Retinal Vein Occlusion
The document provides a completed clinical trial update on using a dexamethasone intravitreal implant for macular edema associated with reti…
-
CLINICAL_TRIALS trial_result · 2018-04-06Clinical Trial Update: Correlation Between the Visual Acuity & the OCT Pattern of Macular Edema Secondary to RVO
This clinical trial update investigates the relationship between visual acuity and OCT patterns in macular edema due to retinal vein occlusi…
-
CLINICAL_TRIALS trial_result · 2018-01-05Clinical Trial Update: Combined Intravitreal Injection of Bevacizumab and Fasudil Versus Bevacizumab Alone for Macular Edema Secondary to Retinal Vein Occlusion in Previously Treated Patients [Phase 2, Phase 3]
A clinical trial comparing combined intravitreal bevacizumab and fasudil versus bevacizumab alone for macular edema due to retinal vein occl…
-
CLINICAL_TRIALS trial_result · 2017-12-02Clinical Trial Update: Ozurdex Implant for Macular Edema After Treatment Failure With Anti-VEGF [NA]
A clinical trial evaluating Ozurdex (dexamethasone intravitreal implant) for macular edema after anti-VEGF treatment failure in retinal vein…
-
CLINICAL_TRIALS trial_result · 2017-10-30Clinical Trial Update: Posterior Vitreous Detachment (PVD) Assessment During Dual Retinal Vein Occlusion (RVO) Lucentis Evaluations [Phase 2]
Phase 2 trial evaluating ranibizumab (Lucentis) for retinal vein occlusion, with assessment of posterior vitreous detachment, is reported as…
-
CLINICAL_TRIALS trial_result · 2017-10-27Clinical Trial Update: Bevacizumab Versus Ranibizumab in Treatment of Macular Edema From Vein Occlusion [NA]
A completed clinical trial compared Bevacizumab to Ranibizumab for macular edema due to retinal vein occlusion.
-
CLINICAL_TRIALS trial_result · 2017-08-25Clinical Trial Update: Prognostic Factors for Visual Improvement in Patients Undergoing Intravitreal Ranibizumab for Retinal Vein Occlusion [NA]
This completed clinical trial evaluated factors that predict visual improvement in patients with retinal vein occlusion undergoing intravitr…
-
CLINICAL_TRIALS trial_result · 2017-07-26Clinical Trial Update: A Study in Patients With Neovascular Age Related Macular Degeneration or Macular Edema Secondary To Retinal Vein Occlusion to Evaluate Usability of the Ranibizumab (Lucentis®) Prefilled Syringe (PFS) [Phase 3]
Phase 3 trial update evaluating the usability of ranibizumab prefilled syringe in patients with neovascular AMD or macular edema due to reti…
-
CLINICAL_TRIALS trial_result · 2017-07-25Clinical Trial Update: 30g vs 33g Needle for Intravitreal Injections [NA]
This completed clinical trial compared 30-gauge versus 33-gauge needles for intravitreal injections in patients with age-related macular deg…
-
CLINICAL_TRIALS trial_result · 2017-07-02Clinical Trial Update: Intravitreal v. Sub-tenon Injections of Triamcinolone Acetonide for Macular Edema in Retinal Disorders [Phase 1]
A Phase 1 trial comparing intravitreal and sub-tenon injections of Triamcinolone acetonide for macular edema in retinal disorders has comple…
-
CLINICAL_TRIALS trial_result · 2017-07-02Clinical Trial Update: Eye Injections of Triamcinolone Acetonide for Retinal Blood Vessel Disorders [Phase 1]
NEI-sponsored Phase 1 trial evaluated intravitreal injections of Triamcinolone Acetonide for age-related macular degeneration and retinal ve…
-
CLINICAL_TRIALS trial_result · 2017-05-31Clinical Trial Update: Efficacy of an Intravitreal DEX Implant in Retinal Vein Occlusion Following Treatment With Anti-VEGF Injections. [Phase 3]
Phase 3 trial evaluating the efficacy of an intravitreal dexamethasone implant in retinal vein occlusion patients after anti-VEGF injections…
-
FDA approval · 2017-05-26FDA Approved: EYLEA — Supplemental Application (Regeneron Pharmaceuticals, Inc.)
FDA approved a supplemental application for EYLEA (aflibercept) submitted by Regeneron Pharmaceuticals, Inc. The action updates labeling and…
-
CLINICAL_TRIALS research · 2017-02-01Clinical Trial Update: DDS-25 Gauge in Patients With Macular Edema Secondary to Retinal Vein Occlusion (RVO) [Phase 1, Phase 2]
A Phase 1/2 clinical trial evaluating the DDS-25 Gauge for macular edema due to retinal vein occlusion has completed.
-
CLINICAL_TRIALS trial_result · 2016-11-18Clinical Trial Update: Efficacy and Safety of Ranibizumab in Japanese Patients With Retinal Vein Occlusion [Phase 3]
Phase 3 trial updates efficacy and safety of ranibizumab in Japanese patients with retinal vein occlusion.
-
CLINICAL_TRIALS trial_result · 2016-09-29Clinical Trial Update: Effect of Intravitreal Ranibizumab Injection With Retinal Vein Occlusion (RVO) [Phase 3]
A Phase 3 trial evaluating intravitreal ranibizumab for macular edema due to retinal vein occlusion has completed.
-
CLINICAL_TRIALS trial_result · 2016-07-27Clinical Trial Update: Anatomic Outcomes Following Ozurdex Injections
A completed clinical trial report detailing anatomic outcomes after intravitreal Ozurdex injections in retinal vein occlusion.
-
CLINICAL_TRIALS trial_result · 2016-07-21Clinical Trial Update: A Safety and Efficacy Study of OZURDEX® in Macular Edema Associated With Branch Retinal Vein Occlusion [Phase 4]
Phase 4 trial update evaluating OZURDEX for macular edema due to branch retinal vein occlusion, with completed status and posted results.